Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer-Reference-Cited by-全球学者库

Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer

Published:2020-12-30 Issue:4 Volume:8 Page:2003263
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

He Yayi¹,Song Lele²³,Wang Hao¹^ORCID,Chen Peixin¹,Liu Yu¹,Sun Hui¹,Li Xiaobin²,Dang Shiying²,Liu Guifeng²,Liu Xinyi²,Chen Shifu²,Zhang Xiaoni²⁴,Hofman Paul⁵,Uchino Junji⁶,Park Henry S.⁷,Pacheco Jose M.⁸,Tabbò Fabrizio⁹,Xu Mingyan²,Dai Jiawei¹⁰,He Kan¹⁰,Yang Yang¹¹,Zhou Caicun¹,

Affiliation:

1. Department of Medical Oncology Shanghai Pulmonary Hospital and Thoracic Cancer Institute Tongji University School of Medicine No. 507, Zhengmin Road, Yangpu District Shanghai 200433 P. R. China

2. HaploX Biotechnology, Co., Ltd. 8th floor, Auto Electric Power Building, Songpingshan Road, Nanshan District Shenzhen Guangdong 518057 P. R. China

3. Department of Radiotherapy the eighth medical center of the Chinese PLA General Hospital No. 17, Heishanhu Road, Haidian District Beijing 100091 P. R. China

4. Shenzhen HaploX Medical Laboratory 1106 South Block of Yuanxing Science and Technology Building, No. 1 Songpingshan Road, Xili Street, Nanshan District Shenzhen Guangdong 518057 P. R. China

5. Laboratory of Clinical and Experimental Pathology FHU OncoAge BB‐0033‐00025 Pasteur Hospital University Côte d'Azur 30 avenue de la voie romaine, Nice cedex 01 Nice 06001 France

6. Department of Pulmonary Medicine Kyoto Prefectural University of Medicine Kyoto 602‐8566 Japan

7. Department of Therapeutic Radiology Yale University School of Medicine New Haven CT 06511 USA

8. Thoracic Oncology Program Division of Medical Oncology Department of Internal Medicine University of Colorado Cancer Center Aurora CO 80045 USA

9. Department of Oncology University of Turin San Luigi Hospital Orbassano Turin 10043 Italy

10. SJTU‐Yale Joint Center for Biostatistics and Data Science Department of Bioinformatics and Biostatistics School of Life Sciences and Biotechnology Shanghai Jiao Tong University Shanghai 200240 China

11. Department of Surgery, Shanghai Pulmonary Hospital Tongji University School of Medicine No. 507, Zhengmin Road, Yangpu District Shanghai 200433 P. R. China

Funder

National Natural Science Foundation of China

Tongji University

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202003263

Reference21 articles.

1. Minimal functional driver gene heterogeneity among untreated metastases

2. NetSig: network-based discovery from cancer genomes

3. Understanding and targeting resistance mechanisms in NSCLC

4. New and emerging targeted treatments in advanced non-small-cell lung cancer

5. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer;Lung Cancer;2024-01

2. Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for Resectable Gastric Cancer;Annals of Surgical Oncology;2023-11-23

3. DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients;Diagnostic Pathology;2023-11-03

4. Synchronized activating therapeutic nano-agent: Enhancement and tracing for hypoxia-induced chemotherapy;Biomaterials;2023-11

5. Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma;Cancer Management and Research;2023-02